171 related articles for article (PubMed ID: 12690972)
1. Itraconazole--perspectives for the management of invasive aspergillosis.
Groll AH
Mycoses; 2002; 45 Suppl 3():48-55. PubMed ID: 12690972
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
[TBL] [Abstract][Full Text] [Related]
6. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
7. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Patterson TF; Kirkpatrick WR; White M; Hiemenz JW; Wingard JR; Dupont B; Rinaldi MG; Stevens DA; Graybill JR
Medicine (Baltimore); 2000 Jul; 79(4):250-60. PubMed ID: 10941354
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Denning DW; Hall L; Jackson M; Hollis S
Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
[TBL] [Abstract][Full Text] [Related]
9. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis.
Bellmann R
Curr Pharm Des; 2013; 19(20):3629-47. PubMed ID: 23278532
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
Patterson TF; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
14. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
15. Intravenous itraconazole.
Slain D; Rogers PD; Cleary JD; Chapman SW
Ann Pharmacother; 2001 Jun; 35(6):720-9. PubMed ID: 11408991
[TBL] [Abstract][Full Text] [Related]
16. Treatment of invasive aspergillosis with itraconazole.
Denning DW; Tucker RM; Hanson LH; Stevens DA
Am J Med; 1989 Jun; 86(6 Pt 2):791-800. PubMed ID: 2543220
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
Berenguer J; Ali NM; Allende MC; Lee J; Garrett K; Battaglia S; Piscitelli SC; Rinaldi MG; Pizzo PA; Walsh TJ
Antimicrob Agents Chemother; 1994 Jun; 38(6):1303-8. PubMed ID: 8092829
[TBL] [Abstract][Full Text] [Related]
18. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
19. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]